BACE2 and melanoma: Indeed, as observed in melanoma cells [10], both pharmacological inhibition and genetic knockdown (Fig. S1A) of BACE2 reduce the level of amyloid aggregates in BXPC3 (Fig. 2D, E; Fig. S1B, C).